The pitch deck version of digital health goes something like this: AI replaces the clinician, costs drop, access expands, outcomes improve, everyone wins. The pitch has been effective. Venture capital has poured billions into companies built around the…
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old…
The company that built TikTok’s recommendation algorithm, the system that predicts with unsettling accuracy what a person wants to watch next, is now using a related class of AI to predict how molecules will behave inside a human body. ByteDance’s drug…
Most of the umbilical cord blood collected at birth is discarded. The tissue is clamped, cut, and disposed of as medical waste, along with the stem cells it contains, cells that are immunologically naive, genetically diverse, and capable of being repro…
The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2027 mbiomics GmbH, a Munich-based techbio company developing microbiome-…
3TS Capital Partners led the round with Grazia Equity and existing investors. 25,000 users, 85% daily wear rate, 500,000+ emergency calls handled. The company is building an AI companion for the watch to address loneliness in the hours when no family m…
Claim Clarity suggests that workers’ compensation represents a significant yet often less visible segment of the broader healthcare ecosystem. Founder and CEO Jamie LaPaglia says, “Its scale and impact continue to expand, but it’s sometimes approached …
Medical alert systems have become an essential safety tool for older adults who want to maintain their independence while ensuring help is available at the press of a button. These devices connect users to trained emergency operators 24/7, providing pe…
The New York startup has built AI that reads handwritten fax forms, processes prior authorisations, and completes patient intakes in under five minutes, all without asking providers to change how they work. It has reached multiple millions in revenue i…
The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of it…